Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Just curious why nobody thought the following was worth discussing
"At January 13, 2011, PDS’ cash and cash equivalents balance was $7,007,897. Management has concluded that PDS’ equity investment at risk is insufficient to finance its activities as the volume of license revenue has not supported litigation costs independent of additional working capital funding."
PDS Balance Sheets
ASSETS:
November 30, 2010
May 31, 2010
Cash and cash equivalents
$ 325,442 $ 779,932
Prepaid expenses
100,000 25,000
Licenses receivable
- 2,000,000
Total assets
$ 425,442 $ 2,804,932
LIABILITIES AND MEMBERS’ EQUITY (DEFICIT):
November 30, 2010
May 31, 2010
Related party payables and accrued expenses
$ 2,361,861 $ 1,777,884
LLC tax payable
- 11,790
Members’ equity (deficit)
(1,936,419 ) 1,015,258
Total liabilities and members’ equity (deficit)
$ 425,442 $ 2,804,932

You all have a nice weekend. We can discuss it on Monday.

Share
New Message
Please login to post a reply